Long-term persistence with anti-osteoporosis drugs after fracture

SUMMARY: Long-term persistence with anti-osteoporosis drugs and determinants for discontinuation among fracture patients were examined. Persistence was 75.0 and 45.3 % after 1 and 5 years, respectively. Those aged ≥80 years were at increased risk of early discontinuation. Within 1 year after discont...

Descripción completa

Detalles Bibliográficos
Autores principales: Klop, C., Welsing, P. M. J., Elders, P. J. M., Overbeek, J. A., Souverein, P. C., Burden, A. M., van Onzenoort, H. A. W., Leufkens, H. G. M., Bijlsma, J. W. J., de Vries, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469296/
https://www.ncbi.nlm.nih.gov/pubmed/25822104
http://dx.doi.org/10.1007/s00198-015-3084-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469296/
https://www.ncbi.nlm.nih.gov/pubmed/25822104
http://dx.doi.org/10.1007/s00198-015-3084-3

Ejemplares similares